Oral Enzastaurin in Participants With Relapsed Mantle Cell Lymphoma
Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
The purposes of this study are to determine the safety of oral enzastaurin and any side
effects that might be associated with it and whether enzastaurin can help participants with
mantle cell lymphoma.